WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010026276) USE OF RAPAMYCIN AND DERIVATIVES FOR THE TREATMENT OF AFRICAN TRYPANOSOMIASIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/026276    International Application No.:    PCT/ES2009/070370
Publication Date: 11.03.2010 International Filing Date: 04.09.2009
IPC:
A61K 31/436 (2006.01), A61P 33/02 (2006.01)
Applicants: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) [ES/ES]; C/ Serrano, 117 E-28006 Madrid (ES) (For All Designated States Except US).
NAVARRO CARRETERO, Miguel Ángel [ES/ES]; (ES) (For US Only).
BARQUILLA PANADERO, Antonio Andrés [ES/ES]; (ES) (For US Only)
Inventors: NAVARRO CARRETERO, Miguel Ángel; (ES).
BARQUILLA PANADERO, Antonio Andrés; (ES)
Agent: PONS ARIÑO, Ángel; Glorieta de Rubén Darío, 4 E-28010 Madrid (ES)
Priority Data:
P200802562 05.09.2008 ES
Title (EN) USE OF RAPAMYCIN AND DERIVATIVES FOR THE TREATMENT OF AFRICAN TRYPANOSOMIASIS
(ES) USO DE LA RAPAMICINA Y DERIVADOS PARA EL TRATAMIENTO DE LA TRIPANOSOMIASIS AFRICANA
(FR) UTILISATION DE LA RAPAMICINE ET DE DÉRIVÉS DE CELLE-CI POUR LE TRAITEMENT DE LA TRYPANOSOMIASE AFRICAINE
Abstract: front page image
(EN)Use of a composition that comprises a TbTOR-inhibiting agent, rapamycin or any of the salts, prodrugs, derivatives or analogues thereof, for the preparation of a drug to prevent and treat African trypanosomiasis.
(ES)Uso de una composición que comprende un agente inhibidor de TbTOR, Ia rapamicina o cualquiera de sus sales, profármacos, derivados o análogos, para Ia elaboración de un medicamento para Ia prevención o el tratamiento de Ia tripanosomiasis africana.
(FR)L'invention concerne l'utilisation d'une composition comprenant un agent inhibiteur de TbTOR, soit de la rapamicine ou n'importe lequel de ses sels, promédicaments, dérivés ou analogues, pour la préparation d'un médicament destiné à prévenir ou traiter la trypanosomiase africaine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Spanish (ES)
Filing Language: Spanish (ES)